Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy
-
Published:2016-04
Issue:
Volume:228
Page:58-66
-
ISSN:0168-3659
-
Container-title:Journal of Controlled Release
-
language:en
-
Short-container-title:Journal of Controlled Release
Author:
Schaal Jeffrey L.ORCID,
Li Xinghai,
Mastria Eric,
Bhattacharyya Jayanta,
Zalutsky Michael R.,
Chilkoti Ashutosh,
Liu WengeORCID
Funder
NIH
Duke Cancer Institute
Subject
Pharmaceutical Science
Reference45 articles.
1. Trends in prostate brachytherapy;Sharkey,2003
2. Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis;Tward;Cancer,2006
3. An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up;Vicini;Cancer,2002
4. Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study;Giberti;World J. Urol.,2009
5. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancer;Kupelian;Int. J. Radiat. Oncol. Biol. Phys.,2004
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献